A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

July 1, 2022

Study Completion Date

July 1, 2022

Conditions

Amyotrophic Lateral SclerosisHealthy Volunteer

Interventions

DRUG

SAR443820

Tablet by oral administration

DRUG

SAR443820

Capsule by oral administration

DRUG

Erythromycin ethyl succinate

Tablet by oral administration

DRUG

Itraconazole

Capsule by oral administration

Trial Locations (1)

Nucleus Network Site Number : 8400001, Saint Paul